Mast Cell Leukemia with Ascites and Multiple Organs Damage
- PMID: 31583006
- PMCID: PMC6742731
- DOI: 10.30699/ijp.2019.96187.1948
Mast Cell Leukemia with Ascites and Multiple Organs Damage
Abstract
Mast Cell Leukemia (MCL), a rare subtype of systemic mastocytosis is defined by bone marrow involvement as atypical and aleukemic mast cells, if more than 20% and less than 10% of peripheral WBCs are mast cells, respectively. We met a case of aleukemic MCL presenting with anemia and ascites for 2 years, referred for BM evaluation, suspicious of leukemia. Our findings included BM involvement by diffused aggregates of oval- and spindle-shaped atypical mast cells, lacking mature mast cells and other hematopoietic cells. The mast cells were absent in peripheral blood smear. Further assessments showed positive reaction of mast cells metachromatic granules with Tryptase, Giemsa and Toluidine blue stains, the expression of CD117/KIT and CD45 by immunohistochemistery, and elevated level of serum Tryptase. Radiologic investigations revealed generalized lymphadenopathy, and massive hepatosplenomegaly, followed by the cervical lymphadenectomy, and liver wedge biopsy. Suspicious peritoneal lesions were identified and underwent excisional biopsy. Microscopic evaluations showed lymph nodes and liver involvement by cancer cells and the same features in peritoneal seeding. Multiple organs damage progressed in few months and the patient died despite surgery and chemotherapy. In conclusion, we report an extremely rare case of aleukemic MCL with multiple organs damage such as liver, peritoneum, spleen, gastrointestinal tract and BM, presenting by ascites. According to this case and previous parallel studies, we suggest some clinicopathologic features in favor of poor prognosis, including the presence of multiple organs damage, hepatomegaly, ascites, peritoneal seeding, the absence of mature mast cells and other hematopoietic cells in the BM, and elevated serum Tryptase level.
Keywords: Ascites; Mast cell leukemia; Multiple organs damage; Prognostic factors; Systemic mastocytosis.
Figures







Similar articles
-
De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child.Diagn Pathol. 2018 Feb 20;13(1):14. doi: 10.1186/s13000-018-0691-2. Diagn Pathol. 2018. PMID: 29458385 Free PMC article.
-
Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V.Leuk Lymphoma. 2004 Nov;45(11):2295-302. doi: 10.1080/10428190412331272695. Leuk Lymphoma. 2004. PMID: 15512820
-
[Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].Wien Klin Wochenschr. 2002 Mar 28;114(5-6):222-8. Wien Klin Wochenschr. 2002. PMID: 12238313 German.
-
Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.Expert Rev Hematol. 2014 Aug;7(4):431-7. doi: 10.1586/17474086.2014.942280. Expert Rev Hematol. 2014. PMID: 25025369 Review.
-
[Systemic mastocytosis].Presse Med. 2005 May 14;34(9):681-7. doi: 10.1016/s0755-4982(05)84013-8. Presse Med. 2005. PMID: 15988348 Review. French.
Cited by
-
Aggressive systemic mastocytosis presenting as rapidly progressive ascites, generalised lymphadenopathy and osteosclerosis.BMJ Case Rep. 2021 Feb 8;14(2):e238034. doi: 10.1136/bcr-2020-238034. BMJ Case Rep. 2021. PMID: 33558379 Free PMC article.
References
-
- Georgin-Lavialle S, Lhermitte L, Dubreuil P, Chandesris MO, Hermine O, Damaj G. Mast cell leukemia. Blood. 2013 ;121(8):1285–95. - PubMed
-
- Parwaresch MR, Homy HP, Lennert K. Tissue mast cells in health and disease. Pathology-Research and Practice. 1985;179(4-5):439–61. - PubMed
-
- Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Human pathology. 1985 ;16(8):808–14. - PubMed
-
- Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 ;127(20):2391–405. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous